BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7737354)

  • 1. The function of inducible promoter systems in F9 embryonal carcinoma cells.
    Miller K; Rizzino A
    Exp Cell Res; 1995 May; 218(1):144-50. PubMed ID: 7737354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive expression of fibroblast growth factor-4 does not alter the growth or the differentiation of embryonal carcinoma cells.
    Miller K; Rizzino A
    Cell Growth Differ; 1996 Feb; 7(2):203-11. PubMed ID: 8822204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vimentin promoter as a tool to analyze the early events of retinoic acid-induced differentiation of cultured embryonal carcinoma cells.
    Benazzouz A; Duprey P
    Differentiation; 1999 Nov; 65(3):171-80. PubMed ID: 10631814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells.
    Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A
    J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
    Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
    Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cis-regulatory elements and transcription factors involved in the regulation of the transforming growth factor-beta 2 gene.
    Scholtz B; Kelly D; Rizzino A
    Mol Reprod Dev; 1995 Jun; 41(2):140-8. PubMed ID: 7654367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly controlled heterologous gene expression through combined utilization of the tetracycline-repressible transactivator and the lac repressor.
    Hoshikawa Y; Amimoto K; Mizuguchi R; Hatakeyama M
    Anal Biochem; 1998 Aug; 261(2):211-8. PubMed ID: 9716424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine Hoxb1 3' RAIDR5 enhancer contains multiple regulatory elements.
    Thompson JR; Huang DY; Gudas LJ
    Cell Growth Differ; 1998 Dec; 9(12):969-81. PubMed ID: 9869297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat tyrosine hydroxylase promoter directs tetracycline-inducible foreign gene expression in dopaminergic cell types.
    Gardaneh M; O'Malley KL
    Brain Res Mol Brain Res; 2004 Jul; 126(2):173-80. PubMed ID: 15249141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the transcription factor Sox-2 in the expression of the FGF-4 gene in embryonal carcinoma cells.
    Johnson LR; Lamb KA; Gao Q; Nowling TK; Rizzino A
    Mol Reprod Dev; 1998 Aug; 50(4):377-86. PubMed ID: 9669521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements.
    Liu HS; Scrable H; Villaret DB; Lieberman MA; Stambrook PJ
    Cancer Res; 1992 Feb; 52(4):983-9. PubMed ID: 1737361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetracycline-inducible transgene expression mediated by a single AAV vector.
    Chtarto A; Bender HU; Hanemann CO; Kemp T; Lehtonen E; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Gene Ther; 2003 Jan; 10(1):84-94. PubMed ID: 12525840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal.
    Yoshida Y; Hamada H
    Biochem Biophys Res Commun; 1997 Jan; 230(2):426-30. PubMed ID: 9016796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the human MSX-1 promoter and an enhancer responsible for retinoic acid induction.
    Shen R; Chen Y; Huang L; Vitale E; Solursh M
    Cell Mol Biol Res; 1994; 40(4):297-312. PubMed ID: 7866431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of inducible expression systems in transient transfection studies.
    Meyer-Ficca ML; Meyer RG; Kaiser H; Brack AR; Kandolf R; Küpper JH
    Anal Biochem; 2004 Nov; 334(1):9-19. PubMed ID: 15464949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
    Kashanchi F; Sadaie MR; Brady JN
    Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells.
    Freundlieb S; Schirra-Müller C; Bujard H
    J Gene Med; 1999; 1(1):4-12. PubMed ID: 10738580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
    Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D
    Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.